Hearing Loss Caused by Chronic Kidney Disease: Evidence of Cochlear Metabolic Disturbances

Scritto il 14/11/2026
da Shu Zheng

Neurosci Bull. 2026 Nov 14. doi: 10.1007/s12264-026-01744-w. Online ahead of print.

ABSTRACT

Hearing loss affects over 1.5 billion people worldwide. Patients with chronic kidney disease (CKD) are at an increased risk of sensorineural hearing impairment, although the mechanisms remain insufficiently understood. Using an adenine-induced mouse model, we evaluated auditory function, cochlear pathology, and metabolism. The mice exhibited significant hearing loss, marked atrophy of the stria vascularis in the middle and basal turns of the cochlea, and pronounced oxidative stress. Metabolomic profiling identified substantial disruptions in cochlear amino acid and lipid metabolism, with concordant metabolic abnormalities in the serum and kidneys. Notably, the uremic toxin, p-cresyl sulfate, was significantly elevated in the cochlea. Overall, CKD induced metabolic disturbances and disrupted tight junction integrity, which may facilitate cochlear accumulation of uremic toxins, trigger oxidative stress, and contribute to hearing loss. These findings provide novel insights into CKD-associated hearing loss and identify potential targets for therapeutic intervention.

PMID:43033370 | DOI:10.1007/s12264-026-01744-w